Dr. Agrawals Eye Hospital Intrinsic Value

Dr. Agrawals Eye Hospital intrinsic value. Dr. Agrawals Eye Hospital (DRAGARWQ) median intrinsic value is ₹2560.65 from 10 valuation models (range ₹1384–₹3939), vs current price ₹5995.50 — -57.3% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse DRAGARWQ FII DII holdings to track promoter, FII and institutional holdings.

Market Price (CMP)
₹5995.50
Primary Intrinsic Value
₹3493.60
Market Cap
₹2998 Cr
-57.3% Downside
Median Value
₹2560.65
Value Range
₹1384 - ₹3939
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

DRAGARWQ Valuation Methods Summary — DCF, Graham Number & P/E

Dr. Agrawals Eye Hospital intrinsic value across 10 models vs current price ₹5995.50 — upside/downside and value range per method. Browse DRAGARWQ annual financials for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹3493.60 ₹2794.88 - ₹4192.32 -41.7% EPS: ₹158.80, Sector P/E: 22x
Book Value Method asset ₹1384.00 ₹1245.60 - ₹1522.40 -76.9% Book Value/Share: ₹692.00, P/B: 2.0x
Revenue Multiple Method revenue ₹2016.00 ₹1814.40 - ₹2217.60 -66.4% Revenue/Share: ₹1008.00, P/S: 2.0x
EBITDA Multiple Method earnings ₹3160.00 ₹2844.00 - ₹3476.00 -47.3% EBITDA: ₹158.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹3939.17 ₹3151.34 - ₹4727.00 -34.3% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹2444.39 ₹2199.95 - ₹2688.83 -59.2% EPS Growth: 19.2%, Fair P/E: 15.4x
Growth Adjusted P/E growth ₹2560.65 ₹2304.59 - ₹2816.72 -57.3% Revenue Growth: 15.0%, Adj P/E: 16.1x
ROE Based Valuation profitability ₹2997.75 ₹2697.97 - ₹3297.53 -50.0% ROE: 22.0%, P/E Multiple: 16x
Graham Defensive Method conservative ₹1798.65 ₹1618.79 - ₹1978.52 -70.0% EPS: ₹158.80, BVPS: ₹692.00
Dividend Yield Method dividend ₹1798.65 ₹1618.79 - ₹1978.52 -70.0% DPS: ₹7.00, Target Yield: 2.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

DRAGARWQ Intrinsic Value vs Market Price — All Valuation Models

Dr. Agrawals Eye Hospital fair value range ₹1384–₹3939 vs current market price ₹5995.50 across 10 valuation models. For current market price and key ratios, visit DRAGARWQ share price screener.

DRAGARWQ Intrinsic Value Analysis — Undervalued or Overvalued?

Dr. Agrawals Eye Hospital median intrinsic value ₹2560.65, current price ₹5995.50 — Trading Above Calculated Value by 57.3%, margin of safety -100.0%.

What is the intrinsic value of DRAGARWQ?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Dr. Agrawals Eye Hospital (DRAGARWQ) is ₹2560.65 (median value). With the current market price of ₹5995.50, this represents a -57.3% variance from our estimated fair value.

The valuation range spans from ₹1384.00 to ₹3939.17, indicating ₹1384.00 - ₹3939.17.

Is DRAGARWQ undervalued or overvalued?

Based on our multi-method analysis, Dr. Agrawals Eye Hospital (DRAGARWQ) appears to be trading above calculated value by approximately 57.3%.

DRAGARWQ Financial Health — Key Ratios vs Industry Benchmarks

Dr. Agrawals Eye Hospital financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 22.0% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 31.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.66x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

DRAGARWQ Cash Flow Quality — Operating & Free Cash Flow

Dr. Agrawals Eye Hospital operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹145 Cr ₹58 Cr Positive Free Cash Flow 7/10
March 2025 ₹94 Cr ₹28 Cr Positive Free Cash Flow 7/10
March 2024 ₹90 Cr ₹55 Cr Positive Free Cash Flow 8/10
March 2023 ₹70 Cr ₹35 Cr Positive Free Cash Flow 7/10
March 2022 ₹57 Cr ₹34 Cr Positive Free Cash Flow 8/10